How Much Did Doseology Sciences Raise?
Funding & Key Investors

Doseology Sciences has reached a significant milestone in its corporate evolution, securing a major strategic investment that underscores its growing influence in the life sciences sector. With a total capital infusion of $2M, the firm is well-positioned to accelerate its research and development initiatives. This latest financing round, totaling $2M, serves as a testament to the market confidence in the company's proprietary oral stimulant and nutraceutical delivery platforms. By leveraging this influx of capital, Doseology Sciences aims to solidify its footprint within the competitive wellness-oriented consumer market.

What is Doseology Sciences?

Doseology Sciences
ManufacturingFood & BeverageHealth & Nutrition Products

Doseology Sciences operates at the intersection of consumer health and advanced life sciences, specializing in the development and commercialization of innovative oral stimulants and nutraceuticals. The company distinguishes itself through a science-driven approach, utilizing sophisticated formulation and delivery technologies to enhance cognitive performance, focus, and energy levels. By prioritizing research-based development and maintaining a rigorous commitment to regulatory compliance and transparent labeling, Doseology Sciences has cultivated a brand identity rooted in credibility and consumer trust. Its market position is defined by its ability to bridge the gap between functional ingredient science and the evolving demands of health-conscious consumers, effectively navigating the complexities of modern wellness markets.

How much funding has Doseology Sciences raised?

Doseology Sciences has raised a total of $2M across 1 funding round:

2026

Stock/Share Issuance

$2M

Stock/Share Issuance (2026): $2M, investors not publicly disclosed

Key Investors in Doseology Sciences

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Doseology Sciences?

Looking ahead, the recent capital injection provides Doseology Sciences with the necessary runway to scale its commercial operations and expand its product pipeline. The company is expected to focus on deepening its research capabilities, potentially exploring new delivery mechanisms that further differentiate its offerings in the crowded nutraceutical space. As the firm transitions into this next phase of growth, strategic priorities will likely include enhancing supply chain transparency and broadening its distribution channels to reach a wider demographic of wellness-oriented consumers. By maintaining its focus on scientific rigor and regulatory excellence, Doseology Sciences is poised to capitalize on the increasing demand for evidence-based cognitive health solutions, setting the stage for long-term brand sustainability and market leadership.

See full Doseology Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Automotive PartsManufacturing
FurnitureManufacturing
ManufacturingPharmaceuticals
ManufacturingPharmaceuticalsBusiness ServicesResearch & Development

Frequently Asked Questions Regarding Doseology Sciences Financial Insights

What are the most recent funding rounds that Doseology Sciences has completed, and what were the funding rounds?
Doseology Sciences has recently completed 1 funding rounds: Stock/Share Issuance on Mar 30, 2026.
What is the total amount of funding Doseology Sciences has raised to date?
Doseology Sciences has raised a total of $2M in funding to date.
How many funding rounds has Doseology Sciences completed?
Doseology Sciences has completed 1 funding rounds.
How much funding did Doseology Sciences raise in its most recent funding round?
Doseology Sciences raised $2M in its most recent funding round.
Which was the largest funding round in Doseology Sciences's history?
The largest funding round in Doseology Sciences's history was $2M.
See more information about Doseology Sciences